NEW YORK, June 19-Aventis has signed a new multi-year deal with Spotfire for expanded use of the database querying and analysis program DecisionSite, the software company said today.
Under the terms of this deal, the two will work jointly to adapt Spotfire software for Aventis' drug discovery efforts. The pharmaceutical company also has access to a new module of the software.
The deal extends an agreement made last June, whereby Spotfire and IBM are collaborating to combine their information management, infrastructure and biological analysis capabilities for the benefit of Aventis.The pharmaceutical giant is using Spotfire and IBM products for all its research and discovery efforts.
For more information, click here.